Clinical trial
Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair - PAPABEAR
NCT00251706 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair - PAPABEAR
- Lead sponsor
- University of Calgary
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 1999
- Completion date
- September 30, 2004
- Enrollment
- 600
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.